Major Developments and Milestones Established This Week for PetroTech, Tanke, Strategic Global, Raptor and Agenus

Major Developments and Milestones Established This Week for PetroTech, Tanke,
                     Strategic Global, Raptor and Agenus

PR Newswire

CORAL SPRINGS, Florida, February 20, 2014

CORAL SPRINGS, Florida, February 20, 2014 /PRNewswire/ --

Market snapshot updates and news developments for advancing cannabis and
healthcare stocks: PetroTech Oil and Gas Inc. (OTC: PTOG), Tanke, Incorporated
(OTC: TNKE), Strategic Global Investments, Inc. (OTC: STBV), Raptor
Pharmaceutical Corp. (NASDAQ: RPTP) and Agenus Inc. (NASDAQ: AGEN).

PetroTech Oil and Gas Inc. (OTC: PTOG) announced the week that they have set
up a subsidiary company in Colorado, and Washington, to serve as the
foundation for the company's entry into the emerging market for medical and
recently legalized recreational marijuana in the United States. PTOG will
leverage its expertise in natural resource development in enhanced oil
recovery and launch LP.US Management Group, Inc. The partnership allows The
Company to secure a leadership position in the rapidly developing marketplace
around legalized Cannabis and Hemp production. LP U.S. Management Group, Inc.
which owns ( is structured around three main
divisions, including Entertainment Arts, Information and News, and Cannabis
and Hemp Production. These divisions will work cohesively to produce and
market medicinal and recreational marijuana, as well as the many fiber, oil
and seed related Hemp products produced for home and commercial use. The
Company is acquiring warehouse facilities in Telluride, CO, and currently has
three growers in Colorado and two in Washington, with immediate plans for
expansion already formalized. 

To read the latest press release, please click

Tanke, Incorporated (OTC: TNKE), a diversified holding company focused on
emerging technologies and "cleantech" is pleased to announced this week the
signing of an incubation, management and investment agreement with Xinyue
Coating and Finishing Ltd., a company headquartered in Jiaxing City, China.
The agreement is expected to bring management revenues of $4.8 million in 2014
and additional incubation and investment revenues of $60 million.

Strategic Global Investments, Inc. (OTC: STBV) is pleased to announce that the
Company has completed negotiations, and has signed an agreement for the
purchase of Bearpot, Inc., controlling entity of an existing Marijuana Growing
facility located in Teller County, Colorado. As a subsidiary of Strategic
Global Inc., Bearpot, Inc. will function as the marijuana incubation and
development sector of the Company. The transaction brings existing equipment
and inventory; creating a successful model that the Company can duplicate as
legalization continues to spread and markets continue to open nationwide and
in Canada.

Raptor Pharmaceutical Corp. (NASDAQ: RPTP) today announced top line results
from a planned 18 month analysis of an ongoing 3 year Phase 2/3 clinical trial
of RP103 (delayed-release cysteamine) for the potential treatment of
Huntington's disease (HD) in collaboration with the Centre Hospitalier
Universitaire d'Angers (CHU d'Angers). A total of 96 patients with HD were
randomized to treatment with RP103 or placebo. Eighty nine patients completed
the initial 18 month phase. Analysis of all 96 patients enrolled in the trial
showed a positive trend towards slower progression of Total Motor Score (TMS)
in patients treated with RP103 vs. those patients on placebo, the primary
endpoint of the study.

Agenus Inc. (NASDAQ: AGEN), a biopharmaceutical company developing novel
immunotherapeutics, including a portfolio of checkpoint modulators (CPMs),
anti-cancer vaccines and adjuvants, today completed the previously announced
acquisition of 4-Antibody AG, a private European-based biopharmaceutical
company.  The acquisition includes the Retrocyte Display® technology platform
which enables rapid discovery and optimization of fully human antibodies
against a wide array of molecular targets. For the past three years,
4-Antibody has been applying Retrocyte Display to create therapeutic
antibodies to six key checkpoint targets that regulate immune response to
cancers and other diseases. The company has multiple preclinical immune CPM
programs in development.. is leading provider of third party publishing &news
dissemination services. If you would like more information regarding our news
coverage solutions, please visit for more
details. Get an edge on the market with ourPremium News Alerts that are
FREE for a limited time at Follow us on
Facebook: and

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNMG is NOT affiliated in any manner
with any company mentioned herein. FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial professional before
considering any level of investing in stocks. The companies that are
discussed in this release may or may not have approved the statements made in
this release. FNMG is not liable for any investment decisions by its readers
or subscribers. Investors are cautioned that they may lose all or a portion
of their investment when investing in stocks. For current services performed
FNMG has been compensated one thousand five hundred fifty dollars for news
coverage of the current press release issued by PTOG by a non-affiliated third


This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email:
U.S. Phone: +1(954)345-0611

SOURCE FN Media Group, LLC
Press spacebar to pause and continue. Press esc to stop.